Cargando…

Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies

Human papillomavirus (HPV) is the causative agent of cervical and other cancers and represents a significant global health burden. HPV vaccines demonstrate excellent efficacy in clinical trials and effectiveness in national immunization programmes against the most prevalent genotype, HPV16. It is un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godi, Anna, Vaghadia, Stuti, Cocuzza, Clementina, Miller, Elizabeth, Beddows, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241894/ https://www.ncbi.nlm.nih.gov/pubmed/35475682 http://dx.doi.org/10.1128/spectrum.00779-22

Ejemplares similares

The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies
por: Bissett, Sara L., et al.
Publicado: (2016)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
por: Godi, Anna, et al.
Publicado: (2015)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay
por: Panwar, Kavita, et al.
Publicado: (2022)

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies
por: Cubillos-Zapata, Carolina, et al.
Publicado: (2020)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
por: Bissett, Sara L., et al.
Publicado: (2014)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women
por: Martinelli, Marianna, et al.
Publicado: (2020)

Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage
por: Marongiu, Luigi, et al.
Publicado: (2014)

Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage
por: Marongiu, Luigi, et al.
Publicado: (2014)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
por: Day, Patricia M., et al.
Publicado: (2015)

Italian observational study on HPV infection, E6, and p16 expression in men with penile cancer
por: Muresu, Narcisa, et al.
Publicado: (2020)

Cross-neutralizing antibodies elicited by the Cervarix(®) human papillomavirus vaccine display a range of Alpha-9 inter-type specificities()
por: Bissett, Sara L., et al.
Publicado: (2014)

Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope
por: Olcese, Vanessa A, et al.
Publicado: (2004)

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology
por: Lee, Sung-Jong, et al.
Publicado: (2013)

Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study
por: Mesher, David, et al.
Publicado: (2016)

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England()
por: Mesher, D., et al.
Publicado: (2013)

Identification of the Neutralizing Epitopes of Merkel Cell Polyomavirus Major Capsid Protein within the BC and EF Surface Loops
por: Fleury, Maxime J. J., et al.
Publicado: (2015)

Maturation of the Human Papillomavirus 16 Capsid
por: Cardone, Giovanni, et al.
Publicado: (2014)

A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
por: Tumban, Ebenezer, et al.
Publicado: (2011)

High resolution cryo EM analysis of HPV16 identifies minor structural protein L2 and describes capsid flexibility
por: Goetschius, Daniel J., et al.
Publicado: (2021)

Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein
por: Ford-Siltz, Lauren A., et al.
Publicado: (2022)

Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity
por: Ren, Jingshan, et al.
Publicado: (2015)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Amino acid sequence diversity of the major human papillomavirus capsid protein: Implications for current and next generation vaccines()
por: Ahmed, Amina I., et al.
Publicado: (2013)

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
por: Arribillaga, Laura, et al.
Publicado: (2020)

Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
por: Draper, Eve, et al.
Publicado: (2011)

Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
por: Yang, Andrew, et al.
Publicado: (2017)

Comparison of Different Self-Sampling Devices for Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs): A Pilot Study
por: Sechi, Illari, et al.
Publicado: (2022)

Cross-reactive antibodies targeting surface-exposed non-structural protein 1 (NS1) of dengue virus-infected cells recognize epitopes on the spaghetti loop of the β-ladder domain
por: Kraivong, Romchat, et al.
Publicado: (2022)

HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London
por: King, Eleanor M, et al.
Publicado: (2021)

Distribution of HPV Genotypes in Patients with a Diagnosis of Anal Cancer in an Italian Region
por: Muresu, Narcisa, et al.
Publicado: (2020)

Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles
por: Li, Haozhou, et al.
Publicado: (2021)

High HPV-51 Prevalence in Invasive Cervical Cancers: Results of a Pre-Immunization Survey in North Sardinia, Italy
por: Piana, Andrea, et al.
Publicado: (2013)

A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein
por: Deng, Yong-Qiang, et al.
Publicado: (2011)

Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
por: Lai, Chih-Yun, et al.
Publicado: (2013)

Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women
por: Hassen, Elham, et al.
Publicado: (2020)

Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors
por: Jimeno, Antonio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qa35ppep5dvql4qd7fhqsremvf